ePlus inc.
In the published model solve dated 2026-Q2, anchored at $94.68, ePlus inc. (PLUS) is priced for +7.3% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed June 28, 2026 from SEC EDGAR filings.
- The price sits within the range the methods support, not above it. At about $82 the market pays roughly 13 times company-wide operating income, which inverts to about 6.7% annual operating growth for five years, a pace ePlus has comfortably delivered. The relative-multiple frame justifies the price; the earnings-power frame says it is modestly full. - Fiscal 2026 was a strong year: revenue up 22% to $2.4 billion, gross billings up 17% to $3.8 billion, services revenue up 15.6%, and adjusted EB
Is PLUS overvalued? See what's priced in →
269 institutional managers reported holding PLUS in 13F filings for the quarter ended 2026-03-31. 36 opened new positions that quarter. Held by BlackRock, Vanguard Group, Dimensional Fund Advisors, among others. On the short side, 1.0M shares were sold short as of the 2026-06-15 count, about 4% of shares outstanding (3.9 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
PLUS has cut its share count 1.8% over the past five years, spending $104.83M on repurchases. It pays a dividend, and has for 1 year running; the current rate is $0.75 a share annually. Cash returned over the past three years: $19.66M in dividends and $80.52M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at PLUS over the trailing three years. Absence is a fact about the company, not a signal. 13 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
PLUS's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2022-11-04 | +4.8% | -7.0% |
| 2023-08-08 | +14.4% | -0.9% |
| 2023-11-09 | +0.7% | +30.2% |
| 2024-05-24 | -0.4% | +16.4% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
PLUS's latest 8-K filings: 2026-08-04 (items 2.02, 8.01, 9.01); 2026-07-06 (items 5.02, 9.01); 2026-05-28 (items 2.02, 8.01, 9.01); 2026-02-17 (items 5.03, 9.01); 2026-02-04 (items 2.02, 8.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 28, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.